| 1 |
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from
the International Lipid Expert Panel
(ILEP)
|
|
|
| Peter E. Penson, Eric Bruckert, David Marais, Željko Reiner, Matteo Pirro, Amirhossein Sahebkar, Gani Bajraktari, Erkin Mirrakhimov, Manfredi Rizzo, Dimitri P. Mikhailidis, Alexandros Sachinidis, Dan Gaita, Gustavs Latkovskis, Mohsen Mazidi, Peter P. Toth, Daniel Pella, Fahad Alnouri, Arman Postadzhiyan, Hung-I Yeh, G.B. John Mancini, Stephan Haehling, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Sonu Bhaskar, Ibadete Bytyçi, Bojko Bjelakovic, Eric Bruckert, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, E |
|
| Journal of Cachexia, Sarcopenia and Muscle. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review |
|
|
| Chong Boon Teo, Pek Yan Tan, Ryan Yong Kiat Tay, Joan Khoo, Gerald F. Watts, Wann Jia Loh |
|
| High Blood Pressure & Cardiovascular Prevention. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Evaluating Statin Tolerability in Historically Intolerant Patients After Correcting for Subclinical Hypothyroidism and Vitamin D Insufficiency |
|
|
| Robert Solomon, Premchand Anne, Jordan Swisher, Beshoy Nazeer, Howard Rosman, Rajendra H. Mehta, James J. Maciejko |
|
| High Blood Pressure & Cardiovascular Prevention. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Comparison of Oral and Injectable Dosage Forms of Vitamin D3 on Resolving Statin-Induced Myopathy: Single Blinded Randomized Controlled Clinical Trial |
|
|
| Reza Ganji,Ahmad Sa’dinpour,Seyed Massoud Seyedian,Saeed Hesam,Nader Afshari,Adeleh Sahebnasagh |
|
| SN Comprehensive Clinical Medicine. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Diagnostik und Therapie von statinassoziierten Muskelsymptomen |
|
|
| Ursula Kassner,Stefanie Grunwald,Dominik Spira,Nikolaus Buchmann,Thomas Bobbert,Elisabetta Gazzerro,Tim Hollstein,Simone Spuler,Elisabeth Steinhagen-Thiessen |
|
| Der Internist. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis |
|
|
| Qingtao Hou,Caishuang Pang,Yuqin Chen |
|
| American Journal of Cardiovascular Drugs. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Advances in the management of statin myopathy |
|
|
| Antonio Gallo,Jeff Perregaux,Eric Bruckert |
|
| Current Opinion in Endocrinology, Diabetes & Obesity. 2021; 28(2): 142 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Vitamin D Supplementation During Statin Rechallenge in Patients With a History of Intolerance |
|
|
| Alison L. P. Compton,Marc J. Pepin,Daniel R. Katzenberger,Debra W. Kemp,Jamie N. Brown |
|
| Annals of Pharmacotherapy. 2021; 55(6): 814 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The role of vitamin D in statin treated patients complaining of myalagia |
|
|
| Noha Hassanin,Yasser Baghdady,Mohamed Shehata,Ashgan Wagdi |
|
| Cor et Vasa. 2021; 63(1): 58 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism |
|
|
| Tara Warren,Roisin McAllister,Amy Morgan,Taranjit Singh Rai,Victoria McGilligan,Matthew Ennis,Christopher Page,Catriona Kelly,Aaron Peace,Bernard M. Corfe,Mark Mc Auley,Steven Watterson |
|
| Cells. 2021; 10(8): 2007 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications |
|
|
| Patrick J. McCullough,William P. McCullough,Douglas Lehrer,Jeffrey B. Travers,Steven J. Repas |
|
| Nutrients. 2021; 13(5): 1511 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease |
|
|
| James T. Reston,Andrew Buelt,Mark P. Donahue,Brian Neubauer,Elena Vagichev,Kristy McShea |
|
| Annals of Internal Medicine. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol – A Cross-sectional Study |
|
|
| Harsheen Kaur,Jagjit Singh,Jeet Ram Kashyap,Ravi Rohilla,Harmanjit Singh,Shivani Jaswal,Rajiv Kumar |
|
| European Endocrinology. 2020; 16(2): 137 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
An overview of statin-induced myopathy and perspectives for the future |
|
|
| Dragana Nikolic,Maciej Banach,Roberta Chianetta,Luca Marco Luzzu,Anca Pantea Stoian,Camelia Cristina Diaconu,Roberto Citarrella,Giuseppe Montalto,Manfredi Rizzo |
|
| Expert Opinion on Drug Safety. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
The Vitamin D Assessment (ViDA) study – Design and main findings |
|
|
| Robert Scragg |
|
| The Journal of Steroid Biochemistry and Molecular Biology. 2020; 198: 105562 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Effects of Vitamin D on drugs: Response and disposal |
|
|
| Jinfu Peng,Yanan Liu,Jinlian Xie,Guoping Yang,Zhijun Huang |
|
| Nutrition. 2020; : 110734 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations |
|
|
| Allyson M. Schweitzer,Molly A. Gingrich,Thomas J. Hawke,Irena A. Rebalka |
|
| European Journal of Applied Physiology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis |
|
|
| Katherine Wong,Alexander Podboy,Jonathan Lavezo,Aparna Goel |
|
| Digestive Diseases and Sciences. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance |
|
|
| Stephen J Nicholls,A Michael Lincoff,Harold E Bays,Leslie Cho,Diederick E Grobbee,John JP Kastelein,Peter Libby,Patrick M Moriarty,Jorge Plutzky,Kausik K Ray,Paul D. Thompson,William Sasiela,Denise Mason,Jaclyn McCluskey,Deborah Davey,Kathy Wolski,Steven E Nissen |
|
| American Heart Journal. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Overview of results from the Vitamin D Assessment (ViDA) study |
|
|
| R. K. R. Scragg |
|
| Journal of Endocrinological Investigation. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Statin-associated muscle symptoms: Does the benefit outweigh the risk factor? |
|
|
| Shannon M. Laboy,Michael T. PULLEY |
|
| Muscle & Nerve. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance |
|
|
| Jordon C. Irwin,Andrew S. Fenning,Rebecca K. Vella |
|
| Translational Research. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Does vitamin D supplementation prevent statin-induced myopathy? |
|
|
| Esther Papp,Edward E. Rylander |
|
| Evidence-Based Practice. 2019; 22(2): 21 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Does vitamin D supplementation reduce the risk of statin-associated myalgia? |
|
|
| Susie Wenstrup,Adriana Santana,Amanda Jamal |
|
| Evidence-Based Practice. 2019; 22(9): 16 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Magnesium Supplementation in Vitamin D Deficiency |
|
|
| Pramod Reddy,Linda R. Edwards |
|
| American Journal of Therapeutics. 2019; 26(1): e124 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain |
|
|
| Manuela Pennisi,Giuseppe Di Bartolo,Giulia Malaguarnera,Rita Bella,Giuseppe Lanza,Michele Malaguarnera |
|
| Disease Markers. 2019; 2019: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Statin Toxicity |
|
|
| Natalie C. Ward,Gerald F. Watts,Robert H. Eckel |
|
| Circulation Research. 2019; 124(2): 328 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Statin-related myopathies |
|
|
| David Hilton-Jones |
|
| Practical Neurology. 2018; 18(2): 97 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Dyslipidaemia in the elderly: to treat or not to treat? |
|
|
| Niki Katsiki,Genovefa Kolovou,Pablo Perez-Martinez,Dimitri P. Mikhailidis |
|
| Expert Review of Clinical Pharmacology. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Important drug-micronutrient interactions: A selection for clinical practice |
|
|
| Uwe Gröber,Joachim Schmidt,Klaus Kisters |
|
| Critical Reviews in Food Science and Nutrition. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study |
|
|
| Zhenqiang Wu,Carlos A. Camargo,Kay-Tee Khaw,Debbie Waayer,Carlene M.M. Lawes,Les Toop,Robert Scragg |
|
| Atherosclerosis. 2018; 273: 59 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases |
|
|
| Parth Shah |
|
| Current Cardiology Reports. 2018; 20(7) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
Statin-Associated Muscle Disease: Advances in Diagnosis and Management |
|
|
| Beth A. Taylor,Paul D. Thompson |
|
| Neurotherapeutics. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen |
|
|
| Gerald Klose |
|
| MMW - Fortschritte der Medizin. 2018; 160(1): 40 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels |
|
|
| Rupinder Singh Buttar,Jasveen Batra,Jacqueline Kreimerman,Melissa Aleta,Michal L. Melamed |
|
| Journal of General Internal Medicine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
Statins Everyday Versus Alternate days: Is There a Difference in Myalgia rates? |
|
|
| Ramsha Riaz,Aleena Zehra Merchant,Muhammad Salman Ul Haq,Syed Ali Raza Nasir,Yusra Rizvi,Jehanzeb Ahmed Khan,Sara Mohiuddin Zakaria,Hassaan Jawed,Khizar Hamid,Noor-ul-ain Zehra,Madiha Ahmed,Hussain Asif Ali,Kaneez Fatima |
|
| Indian Heart Journal. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Practical aspects in the management of statin-associated muscle symptoms (SAMS) |
|
|
| Ulrich Laufs,Krysztof J. Filipiak,Ioanna Gouni-Berthold,Alberico L. Catapano,Giuseppe Mandraffino,Pascale Benlian |
|
| Atherosclerosis Supplements. 2017; 26: 45 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort |
|
|
| Nikhil Sharma,Rachel Cooper,Diana Kuh |
|
| Scientific Reports. 2017; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Myotoxicity of statins: Mechanism of action |
|
|
| Patrick du Souich,Ghislaine Roederer,Robert Dufour |
|
| Pharmacology & Therapeutics. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Neurological Complications of Nutritional Deficiencies |
|
|
| Aparna Polavarapu,Daphne Hasbani |
|
| Seminars in Pediatric Neurology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Vitamin D Deficiency, Supplementation, and Cardiovascular Health |
|
|
| Naveen Trehan,Luis Afonso,Diane L. Levine,Phillip D. Levy |
|
| Critical Pathways in Cardiology. 2017; 16(3): 109 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Trial designs for statin muscle intolerance |
|
|
| Robert S. Rosenson |
|
| Current Opinion in Lipidology. 2017; 28(6): 488 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients |
|
|
| Leonardo Calza,Eleonora Magistrelli,Vincenzo Colangeli,Marco Borderi,Ilaria Contadini,Isabella Bon,Maria Carla Re,Pierluigi Viale |
|
| AIDS. 2017; 31(5): 681 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Statin Use and 25-Hydroxyvitamin D Blood Level Response to Vitamin D Treatment of Older Adults |
|
|
| Heike A. Bischoff-Ferrari,Karina Fischer,Endel J. Orav,Bess Dawson-Hughes,Ursina Meyer,Patricia O. Chocano-Bedoya,Otto W. Meyer,Rahel Ernst,Simeon Schietzel,Franz Eberli,Hannes B. Staehelin,Gregor Freystätter,Susanne Roas,Robert Theiler,Andreas Egli,Nicholas M. Wilson |
|
| Journal of the American Geriatrics Society. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care |
|
|
| Susan E. Merel,Douglas S. Paauw |
|
| Journal of the American Geriatrics Society. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study |
|
|
| Parth Shah,Charles J. Glueck,Naila Goldenberg,Sarah Min,Chris Mahida,Ilana Schlam,Matan Rothschild,Ali Huda,Ping Wang |
|
| Lipids in Health and Disease. 2017; 16(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study |
|
|
| Joshua Choi,Amir M Khan,Michael Jarmin,Naila Goldenberg,Charles J Glueck,Ping Wang |
|
| Lipids in Health and Disease. 2017; 16(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
Statins, Muscle Disease and Mitochondria |
|
|
| Radha Ramachandran,Anthony Wierzbicki |
|
| Journal of Clinical Medicine. 2017; 6(8): 75 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Lifestyle, Lipids, and Cardiovascular Risk Reduction in a Woman With Metabolically Unhealthy Normal Weight |
|
|
| Cynthia Geyer |
|
| American Journal of Lifestyle Medicine. 2016; 10(5): 348 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol =70 mg/dl despite maximal tolerated cholesterol lowering therapy |
|
|
| Charles J. Glueck,Parth Shah,Naila Goldenberg,Marloe Prince,Kevin Lee,Vybhav Jetty,Ashwin Kumar,Michael Goldenberg,Ping Wang |
|
| Lipids in Health and Disease. 2016; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center |
|
|
| Parth Shah,Charles J. Glueck,Vybhav Jetty,Naila Goldenberg,Matan Rothschild,Rashid Riaz,Gregory Duhon,Ping Wang |
|
| Lipids in Health and Disease. 2016; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Statin myopathy |
|
|
| Negar Maghsoodi,Anthony S. Wierzbicki |
|
| Current Opinion in Cardiology. 2016; 31(4): 417 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Safe use of statins: focus on muscle toxicity |
|
|
| Vana Kolovou, Helen Bilianou, Genovefa Kolovou |
|
| Clinical Lipidology. 2016; 11(1): 16 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 54 |
The Risks and Benefits of Sun Exposure 2016 |
|
|
| David G. Hoel,Marianne Berwick,Frank R. de Gruijl,Michael F. Holick |
|
| Dermato-Endocrinology. 2016; : 00 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 55 |
¿Existe relación entre los niveles séricos de vitamina D (25OHD) y el dolor musculoesquelético relacionado con la ingesta de estatinas? Revisión sistemática |
|
|
| Claudia Alejandra Pereda,Maria Betina Nishishinya |
|
| Reumatología Clínica. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 56 |
Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review |
|
|
| Claudia Alejandra Pereda,Maria Betina Nishishinya |
|
| Reumatología Clínica (English Edition). 2016; 12(6): 331 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 57 |
Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)1 |
|
|
| Harold Bays,Shanu N. Kothari,Dan E. Azagury,John M. Morton,Ninh Nguyen,Peter H. Jones,Terry A. Jacobson,David Cohen,Carl Orringer,Eric C. Westman,Deborah B. Horn,Wendy Scinta,Craig Primack |
|
| Surgery for Obesity and Related Diseases. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 58 |
Statin intolerance – a question of definition |
|
|
| Engi Abdel-Hady Algharably,Iris Filler,Stephanie Rosenfeld,Katja Grabowski,Reinhold Kreutz |
|
| Expert Opinion on Drug Safety. 2016; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 59 |
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol |
|
|
| Laura A. Della Badia,Nabil A. Elshourbagy,Shaker A. Mousa |
|
| Pharmacology & Therapeutics. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 60 |
Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) |
|
|
| G. B. John Mancini,Steven Baker,Jean Bergeron,David Fitchett,Jiri Frohlich,Jacques Genest,Milan Gupta,Robert A. Hegele,Dominic Ng,Glen J. Pearson,Janet Pope,A. Yashar Tashakkor |
|
| Canadian Journal of Cardiology. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 61 |
Statin-related myotoxicity |
|
|
| Vera Fernandes,Maria Joana Santos,Antonio Pérez |
|
| Endocrinología y Nutrición (English Edition). 2016; 63(5): 239 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 62 |
Statin-related myotoxicity |
|
|
| Vera Fernandes,Maria Joana Santos,Antonio Pérez |
|
| Endocrinología y Nutrición. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 63 |
Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? |
|
|
| Amirhossein Sahebkar,Nikou Saboni,Matteo Pirro,Maciej Banach |
|
| Journal of Cachexia, Sarcopenia and Muscle. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 64 |
Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons |
|
|
| Seema Patel |
|
| World Journal of Microbiology and Biotechnology. 2016; 32(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 65 |
Current Use of Statins for Primary Prevention of Cardiovascular Disease: Patient-Reported Outcomes and Adherence |
|
|
| Scott A. Coon,Emily J. Ashjian,Megan C. Herink |
|
| Current Cardiovascular Risk Reports. 2016; 10(7) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 66 |
Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain |
|
|
| Beth A. Taylor,Lindsay Lorson,Michael White,Paul D. Thompson |
|
| Atherosclerosis. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 67 |
Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon |
|
|
| Chandan Prasad,Victorine Imrhan,Shanil Juma,Mindy Maziarz,Anand Prasad,Casey Tiernan,Parakat Vijayagopal |
|
| Metabolites. 2015; 5(4): 733 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
